ochers have shown. by NMR spectroscopy that ischaemia produces a degradation of phosphocreatine (PCr) and ATP. We tested the feasibility of NMR spectroscopy for gaining kinetic data on the degradation of PCr and ATP at different body temperatures.
and ATP. We tested the feasibility of NMR spectroscopy for gaining kinetic data on the degradation of PCr and ATP at different body temperatures.
Anaesthesized rabbits were ventilated and cooled externally to 2 4 ' C and 21 0 C respectively. NMR spectra of 31P phosphates were recorded using a 1.9 Tesla. 24 cm bore superconducting magnet. Degradation kinetics of the compounds were measured after cardiac arrest at 35O. 24 O and 21°. The decay of PCr and ATP followed a single exponential function, indicating first order kinetics. The half time values (Tl2) are given in the table (4 animals per temperature; SO) 35°C 24OC 2 P C TI2 PCr (min) 1 9 t 8 4 B * 6 6 3 + 1 9 TI2 ATP (min) Cardiocytes of h m atria possess granules similar to those of endocrine glands. These granules wntain polypeptides with potent natriuretic and vasorelaxing properties (atrial natriuretic peptide = ANP) .
The presence of ANP in circulating blmd has not yet been h m t r ated in h m peripheral b l d . Using a specific and sensitive radioimnmassay, we were able to de tect and guantitate ANP in plasm of normal children (n=51) and of children with cardiovascular diseases (n=lB) . In n o m l children, the m%=m ANP plasm mnoentration was 27.5 h l / m l (range 1 -45.5 h 1 / ml). There was no significant difference of ANP-levels between infants (n=12) and older children (n=39). H o d e v e r , in patients with cardiovascular diseases such as congenital heart malfonmtioffi arm3 brunchcpulm n q Qsplasia, ANP-levels were up to 20 tines higher (wan 162.7 h l / l ; range 37 -537 hl/ml) when c a p x e d with the m value in n o d children. 15 out of 18 patients exceeded the upper range of ANP-levels in omtrols. Furthenmre, in critically ill children (n=3) , ANP-levels were markedly higher at the tirre of hospital aCbnission (range 92.5 -266.6 hl/ml) than after therapy (range 25.8 -55.1 hl/ml) . In accordance to observations in exprimstdl aninnls, o w finduqs suggest that atrial distension caused the increased ANP-release in our patients with cardiac diseases. w a s u r e n t of ANP-levels may be a useful tool to assess circulatoq status in cardiac diseases.
Abnormalities at a cellular level in relation to the We compared in vi tro responses of leucocytes (study I) in asthmatic children with various degrees of BnR and in healthy children. Cell responses were assessed by the generation of superoxide anion (02-) and the relea of histamine after challenge with calcium ionophore k 23187 plus C a 3 ' , and with deuterium oxide ( D 0). BhR was graded on the basis of responses to inhaled histamine and $0 exercise. The mean generation of 0 and the mean release of histamine by the Ca ionophore and by D 6-were significantly greater in the asthmatics than in the heal thy suijects (P'0.05 and P'0.025 respectively). Between patients with pronounced and limited BhR the histamine release but not the 02-generation was significantly different (P'0.0251. In study I1
cal ci um i nf 1 ux, change in membrane potenti a1 and histamine re1 ease after anti-IgE, Ca ionophore and D20 were measured in a suspension of basophil s, selected by a fluorescence activated cell sorter. (Purity 60%. recovery 20%, high reproducibility). Results of study I and preliminary results of study I1 suggest a basic intracellular abnormal i ty in asthma and BtiR. After preliminary characterization of C3 converting factor (C3 CoF) the question was raised whether this factor was a "true" activator of C3, i.e. generates C3a and C3b on interaction with native C3. For this purpose C3 NeF and C3 CoF activity were separated from each other by euglobulin precipitation and anion exchange chromatography using a discontinuous salt gradient. The C3 CoF containing fraction was devoid IgG. To identify the site of cleavage in the C3 molecule C3 was isolated from normal human serum to apparent homogeneity and radiolabelled with 125-iodine using the Bolten-Hunter method. Incubation of this radiolabelled C3 with C3 CoF isolated from patient's serum generated two major C3 fragments identified by autoradiography following SDS-PAGE under reducing conditions: A large fragment with 117 kD and a small fragment with approx. 10 kD. Following autoradiography proteins were transblotted on nitrocellulose and analyzed for expression of C3 antigens using the Western blot technique and monospecific antisera to C3a and C3c. The 117 kD fragment expressed C3c antigen but no C3a antigen, the 10 kD fragment expressed C3a antigen only indicating that C3 was, indeed, cleaved into C3a and C3b. We conclude that C3 CoF is a "true" activator of C3. The generation of the peripheral T-cell pool is attributed to maturation and differentiation events occurring within the thymus. Three thymic compartments, thymic epithelial cells, thymic hormons and thymic MB are considered to contribute to the intrathymic T-cell developnent. While, as we have shown earlier, murine as well as human MHC-Ia-negative-K$ (I~-MB) replate thymocyte (TH) differentiation via suppressive effects (Thymus,6:295,1984 ) and MHC-Ia -K$ are involved in intrathymic tolerance induction (Pediatr Res,15:800,1984) , now the contribution of I~+MB to intrathymic lymphopoiesis was investigated. An isolation method yielding cell suspensions highly enriched for 1a+ thymic Md was performed (pA-gradient,antibody treatment,irradiation). C-ltivation of these Ia MB with TH showed that I~+M@ strongly augmented the mitqen-induced proliferation of TH by about 200%. The effect was dependent on the number of 1 a +~ added and on the degree of TH maturity: stronger augmentation occurred at higher MB concentrations) immature TH s h o d highest susceptibility to the I~+M$ mediated effect. Cell-cell-contact was an important prerequisite for the proliferation amplifying effect as demonstrated by use of Cytochalasin B. In addition, humoral factors produced by 1 a +~ also improved the proliferative capacity of TH, similar to results obtained using interleukin 11. The results described support the view that thymic MB poqulations act as a main regulatory principle in T-cell developnent. Ia MB augment intrathymic lymphopoiesis and participate in tolerance induction,while 1a-I+$ control the number of TH finally leaving the thymus gland. concentrations of dADO in the presence of an adenosine-deaminase (ADA) inhibitor such as DCF. Therefore, this drug combination was investigated for its ability to deplete T cells from allogeneic rat bone marrow (EM) and spleen (SP) cells and for its potential to prevent G W D in fully allogeneic rat bone marrow transplantationLBMT), -It was found that a concentration of 0.5 Cul of DcF was sufficient to block ADA-activity in rat BM and SP cells completely. Concentrations as high as 100 W were not toxic to in vitro colony forming units (CFU-GM). Iqcreasing dADO concentrations in the presence of DCF led to increasing T cell but also increasing CFU toxicity.
PROMOTICN OF IWIRATHYMIC T-CELL
However, dADO concentrations below 40 W had no significant influence on CFU growth but clearly exhibited an effect on T cells. T cell functions, as determined by mitogen and alloantigen stimulated thymidine (3HTdR) uptake, were reduced to 10-30% of normal values. Flowcytometric analysis revealed a significant T cell reduction following in vitro treatment. However, some residual T cells were detectable in treated samples. -In accordance with the described in vitro data, rat-recipients of DCF/dAW treated allogeneic BM and SP cell grafts showed a significantly decreased incidence of acute lethal GVHD. -The results indicate that a significant but incomplete depletion of T cells can be achieved through DCF/dADO in vitro treatment using concentrations which are not toxic for stem cells. Such T cell depletion results in modification of acute lethal G W D into a chronic form in fully allogeneic rat BMT.
